BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 7295464)

  • 1. Circulatory and metabolic effects of a combined alpha- and beta-adrenoceptor blocker (labetalol) in hypertension of pregnancy.
    Lunell NO; Hjemdahl P; Fredholm BB; Nisell H; Persson B; Wager J
    Br J Clin Pharmacol; 1981 Sep; 12(3):345-8. PubMed ID: 7295464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol, a combined alpha- and beta-blocker, in hypertension of pregnancy.
    Lunell NO; Fredholm B; Hjemdahl P; Lewander R; Nisell H; Nylund L; Persson B; Sarby B; Wager J
    Acta Med Scand Suppl; 1982; 665():143-7. PubMed ID: 6961761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
    Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
    Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative effects of an alpha 1 and beta 1-2 blocker (labetalol) and a beta-1 blocker (atenolol) in the hypertensive patient].
    Sassard J; Zech PY; Pozet N; Cuisinaud G; Vincent M
    J Pharmacol; 1983; 14 Suppl 2():121-9. PubMed ID: 6355664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis.
    Saotome T; Minoura S; Terashi K; Sato T; Echizen H; Ishizaki T
    J Clin Pharmacol; 1993 Oct; 33(10):979-88. PubMed ID: 8227470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interdose control of beta-blockade and arterial blood pressure during chronic oral labetalol treatment.
    Sanders GL; Murray A; Rawlins MD
    Br J Clin Pharmacol; 1979; 8(Suppl 2):125S-127S. PubMed ID: 43163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of labetalol on plasma renin, aldosterone, and catecholamines in hypertensive patients.
    Lijnen PJ; Amery AK; Fagard RH; Reybrouck TM; Moerman EJ; De Schaepdryver AF
    J Cardiovasc Pharmacol; 1979; 1(6):625-32. PubMed ID: 94628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of labetalol on plasma noradrenaline and adrenaline in hypertensive man.
    Christensen NJ; Trap-Jensen J; Svendsen TL; Rasmussen S; Nielsen PE
    Eur J Clin Pharmacol; 1978 Dec; 14(4):227-30. PubMed ID: 365539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol: a review of its pharmacology, pharmacokinetics, clinical uses and adverse effects.
    MacCarthy EP; Bloomfield SS
    Pharmacotherapy; 1983; 3(4):193-219. PubMed ID: 6310529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of labetalol and methyldopa in pregnancy-induced hypertension.
    Lamming GD; Symonds EB
    Br J Clin Pharmacol; 1979; 8(Suppl 2):217S-222S. PubMed ID: 526404
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Lamming GD; Broughton Pipkin F; Symonds EM
    Clin Exp Hypertens (1978); 1980; 2(5):865-95. PubMed ID: 7428566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of 2 beta-blockers on arterial hypertension during pregnancy. Results of a prospective study on 56 pregnant hypertensive women treated with atenolol and labetalol].
    Gérard J; Blazquez G; Lardoux H; Beauséjour B; Faurie C; Rousset D; Flouvat B
    J Gynecol Obstet Biol Reprod (Paris); 1983; 12(8):891-900. PubMed ID: 6672083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of labetalol in the treatment of severe hypertension during pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):211S-215S. PubMed ID: 526403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of acute pregnancy-related hypertension: labetalol and hydralazine compared.
    Walker JJ; Greer I; Calder AA
    Postgrad Med J; 1983; 59 Suppl 3():168-70. PubMed ID: 6647203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.
    Prichard BN; Richards DA
    Br J Clin Pharmacol; 1979; 8(Suppl 2):239S-244S. PubMed ID: 526408
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.